Here’s Why Transgender Women Face A Far Higher Risk Of Heart Attack

For post-menopausal women, a five-year course of aromatase inhibitors appears to offer more potent breast cancer prevention than the two drugs long known to have such effects — tamoxifen (sold as Nolvadex and Soltamox) and raloxifene (Evista). In studies, women taking aromatase inhibitors were more likely to experience hot flashes and pain in their bones and muscles compared with women taking a dummy pill. But preliminary signs showed no significant increase in the risk of blood clots.

Source : https://www.latimes.com/science/sciencenow/la-sci-sn-breast-cancer-prevention-20190115-story.html

Preventing breast cancer just got easier. Will more women give these drugs a try?
Diabetic women at 34 percent higher risk of heart attack than diabetic men as they age
Why Transgender People Are Being Murdered at a Historic Rate
Unanswered questions about elderly woman’s death at homeless shelter show why people are choosing tents over beds
Gillette leaps into culture wars with ad challenging images of masculinity
If men are favored in our society, why do they die younger than women?
Heart Attacks Are Different in Women – and It’s Time We Treat Them That Way
7 Reasons Why the Transgender Revolution Will Fail
From whether exercise or dieting will REALLY make you lose weight to the toxic truth behind 'Wine o'clock', TV twin doctors Dr Xand and Chris van Tulleken reveal their anti ...
Women once considered low risk for heart disease show evidence of previous heart attack scars